The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease

McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bolaños-Meade J, Rosner GL, et al. Risk-stratified outcomes of nonmyeloablative hla-haploidentical bmt with high-dose posttransplantation cyclophosphamide. Blood. 2015;125:3024–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang Y, Wang Y, Liu Y, Xu L, Zhang X, Chen H, et al. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of aml patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis. J Hematol Oncol 2017;10:134.

Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of aml in adults: 2017 eln recommendations from an international expert panel. Blood. 2017;129:424–47.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Liu Q, Xu L, Liu K, Zhang X, Ma X, et al. Haploidentical vs identical-sibling transplant for aml in remission: a multicenter, prospective study. Blood. 2015;125:3956–62.

Article  CAS  PubMed  Google Scholar 

Wood BL. Flow cytometric monitoring of residual disease in acute leukemia. Totowa, NJ: Humana Press; 2013, 999, pp 123–36.

Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H, et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood. 2012;119:3256–62.

Article  CAS  PubMed  Google Scholar 

Wang Y, Fu HX, Liu DH, Xu LP, Zhang XH, Chang YJ, et al. Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial. Bone Marrow Transpl. 2014;49:426–33.

Article  CAS  Google Scholar 

Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56.

Article  Google Scholar 

Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute gvhd grading. Bone Marrow Transpl. 1995;15:825–8.

CAS  Google Scholar 

Wood BL. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia. Clin Lab Med. 2007;27:551–75.

Article  PubMed  Google Scholar 

Chang YJ, Xu LP, Wang Y, Zhang XH, Chen H, Chen YH, et al. Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation. J Clin Oncol. 2016;34:1855–63.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif